transplant
remyelinationcompet
cell
repres
promis
strategi
treatment
demyelin
diseas
environ
dictat
success
failur
remyelin
critic
understand
role
immun
system
play
transplantmedi
remyelin
studi
evalu
sever
neuroinflamm
follow
transplant
glialcommit
progenitor
cell
spinal
cord
mice
chronic
infect
mous
hepat
viru
mhv
model
cell
macrophag
critic
amplifi
sever
demyelin
transplant
perform
follow
viral
persist
inflamm
demyelin
establish
clinic
diseas
evid
mice
sacrif
day
follow
progenitor
cell
transplant
effect
neuroinflamm
evalu
treatment
alter
accumul
cell
macrophag
within
cn
compar
control
mice
moreov
progenitor
cell
implant
affect
local
cytokinechemokin
gene
express
cn
final
remyelin
associ
transplant
result
imbal
h
cytokin
product
virusspecif
cell
studi
demonstr
progenitor
cellmedi
remyelin
result
modul
composit
cellular
infiltr
cytokin
express
virusspecif
cell
suggest
remyelin
may
depend
amelior
inflammatori
respons
alter
cytokin
secret
virusspecif
cell
multipl
sclerosi
ms
chronic
demyelin
diseas
character
inflamm
central
nervou
system
cn
lead
demyelin
axon
loss
disabl
sospedra
martin
mani
treatment
gear
toward
reduc
neuroinflamm
ultim
goal
reduc
progress
diseas
rizvi
agiu
howev
treatment
often
address
neurodegen
phase
diseas
remyelin
occur
spontan
adult
human
brain
evidenc
shadow
plaqu
larg
region
white
matter
undergo
remyelin
characterist
thin
myelin
sheath
halfpenni
et
al
howev
remyelin
occur
uniformli
within
lesion
across
mani
lesion
two
major
process
propos
explain
failur
remyelin
ms
notabl
difficulti
recruit
oligodendrocyt
precursor
cell
opc
area
activ
demyelin
ii
inhibit
differenti
opc
oligodendrocyt
capabl
remyelin
franklin
two
process
signal
growth
factor
cytokineschemokin
extracellular
matrix
molecul
thought
contribut
environ
conduc
promot
remyelin
studi
anim
model
proven
invalu
identifi
new
method
induc
remyelin
anim
establish
demyelin
exampl
transplant
stem
cell
anim
model
acut
demyelin
result
remyelin
cao
et
al
transplant
rodent
embryon
stem
cell
myelindefici
shiver
mice
result
cellular
migrat
spinal
cord
differenti
oligodendrocyt
astrocyt
myelin
axon
brustl
et
al
similarli
transplant
human
embryon
stem
cellderiv
oligodendrocyt
progenitor
cell
myelindefici
shiver
mice
result
oligodendrocyt
differenti
remyelin
nistor
et
al
model
demyelin
also
report
reduc
demyelin
follow
transplant
stem
cell
inject
adult
neuron
precursor
mice
experiment
autoimmun
encephalomyel
eae
result
recoveri
diseas
signific
decreas
level
demyelin
pluchino
et
al
similarli
transplant
stromal
bone
marrow
cell
demyelin
rat
spinal
cord
result
remyelin
akiyama
et
al
studi
util
mous
hepat
viru
mhv
murin
coronaviru
model
ms
defin
impact
transplant
inflammatori
respons
associ
diseas
cn
infect
suscept
mice
mhv
result
acut
encephalomyel
follow
immunemedi
demyelin
diseas
similar
ms
demyelin
mhvinfect
mice
associ
impair
motor
skill
often
associ
immun
cell
infiltr
white
matter
tract
lane
buchmeier
due
similar
clinic
histolog
diseas
ms
mhvinduc
demyelin
mhv
model
consid
relev
model
studi
underli
immunopatholog
mechan
contribut
ongo
myelin
destruct
well
clinic
diseas
recent
studi
totoiu
et
al
use
mhv
model
chronic
demyelin
determin
cellular
transplant
modul
diseas
sever
transplant
glialcommit
progenitor
cell
mhvinfect
mice
ongo
demyelin
establish
clinic
diseas
result
remyelin
improv
locomot
studi
highlight
efficaci
cellular
transplant
therapi
promot
remyelin
model
extens
cellular
infiltr
demyelin
provid
us
opportun
investig
role
inflamm
play
regen
process
report
cellular
transplant
result
remyelin
alter
inflamm
cn
modul
ongo
immun
respons
mhv
studi
impli
modul
inflammatori
environ
requir
remyelin
find
profound
implic
develop
cellular
replac
strategi
treat
demyelin
diseas
agematch
week
male
mice
b
background
use
studi
nation
cancer
institut
bethesda
md
follow
anesthet
ketamin
phoenix
st
joseph
mo
mice
inject
intracrani
ic
pfu
mhv
strain
suspend
steril
hank
balanc
salt
solut
hbss
control
anim
sham
inject
hbss
alon
anim
euthan
day
postinfect
pi
correspond
day
transplant
point
brain
spinal
cord
spleen
remov
analysi
cell
transplant
cultur
striata
postnat
day
mice
previous
describ
cultur
day
transplant
totoiu
et
al
striata
region
brain
chosen
contain
periventricular
area
rich
neurogen
stem
cell
twelv
day
ic
infect
mhv
cell
inject
dmem
gibcoinvitrogen
spinal
cord
totoiu
et
al
control
anim
receiv
ic
infect
mhv
inject
dmem
alon
spinal
cord
totoiu
et
al
anim
euthan
inhal
halothan
sigma
st
loui
mo
day
follow
transplant
fix
cardiac
perfus
paraformaldehyd
fisher
scientif
glutaraldehyd
fisher
scientif
pittsburgh
pa
pb
ph
length
spinal
cord
extend
mm
cranial
mm
caudal
site
implant
extract
process
resin
glutaraldehyd
fix
sampl
cryostat
section
paraformaldehyd
fix
sampl
previous
describ
totoiu
et
al
briefli
block
cut
mm
spinal
cord
section
cranial
caudal
site
transplant
even
block
process
immunohistochemistri
odd
number
block
process
resin
embed
toludin
blue
stain
total
block
cut
either
side
transplant
site
resin
section
block
expos
electron
microscopi
scienc
fort
washington
pa
dehydr
ascend
alcohol
embed
spurr
resin
electron
microscopi
scienc
accord
standard
protocol
transvers
section
cut
cranial
face
block
stain
alkalin
toluidin
blue
cover
slip
examin
light
microscopi
olympu
microscop
use
olympu
microsuit
softwar
state
myelin
determin
assess
thick
myelin
sheath
relat
axon
diamet
guy
et
al
hildebrand
hahn
demyelin
remyelin
normal
myelin
axon
count
within
area
total
tissu
section
use
object
optic
zoom
repres
approxim
total
area
remyelin
within
transplant
anim
determin
measur
total
area
remyelin
section
block
anim
use
object
averag
area
anim
group
quantit
assess
conduct
throughout
region
extend
mm
cranial
mm
caudal
transplant
site
number
demyelin
axon
remyelin
axon
total
number
axon
percentag
remyelin
axon
determin
four
region
tissu
block
averag
averag
across
anim
within
group
tissu
block
previous
describ
totoiu
et
al
statist
analys
conduct
use
spss
softwar
chicago
il
cryostat
section
block
cryoprotect
sucros
solut
pb
embed
oct
fisher
scientif
frozen
section
transvers
plane
jung
leica
cryostat
antibrdu
stain
previous
describ
totoiu
et
al
cell
obtain
pool
brain
spinal
cord
mice
base
describ
protocol
pew
et
al
singl
cell
suspens
obtain
grind
tissu
steril
tissu
cultur
plate
ice
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
cell
suspens
transfer
conic
tube
percol
amersham
uppsala
sweden
ad
final
concentr
one
ml
percol
underlaid
cell
spun
g
min
cell
remov
interfac
wash
use
flow
cytometri
fc
receptor
block
incub
cell
dilut
rat
antimous
iiiii
receptor
pharmingen
san
diego
ca
min
subject
stain
activ
macrophagesmicroglia
identifi
dual
stain
fitcconjug
rat
antimous
serotec
oxford
england
peconjug
pharmingen
presenc
cell
recogn
immunodomin
epitop
locat
within
surfac
glycoprotein
within
residu
determin
use
peconjug
b
major
histocompat
class
tetram
trifilo
et
al
cell
surfac
express
determin
use
apcconjug
rat
antimous
pharmingen
cell
incub
antibodi
min
wash
analyz
facscalib
becton
dickinson
mountain
view
ca
presenc
virusspecif
cell
determin
intracellular
cytokin
stain
peconjug
pharmingen
follow
stimul
immunodomin
epitop
present
within
matrix
glycoprotein
span
residu
medium
contain
golgistop
use
cytofixcytoperm
kit
pharmingen
accord
manufactur
protocol
glass
et
al
cell
wash
block
pb
contain
fb
dilut
cell
stain
peconjug
min
follow
fix
stain
intracellular
use
min
glass
et
al
cell
wash
analyz
facscalib
data
present
percent
posit
within
gate
popul
numer
base
number
total
live
cell
per
tissu
total
number
cell
calcul
multipli
percentag
posit
live
cell
total
number
isol
cell
frequenc
virusspecif
cell
determin
divid
total
number
antigenspecif
cell
total
number
gate
cell
total
rna
extract
brain
spinal
cord
mhvinfect
mice
day
pi
day
posttranspl
cytokin
chemokin
chemokin
receptor
transcript
analyz
use
custom
probeset
pharmingen
rpa
analysi
perform
total
rna
use
previous
describ
protocol
lane
et
al
probe
gapdh
includ
verifi
consist
rna
load
assay
perform
quantif
signal
intens
autoradiograph
scan
individu
transcript
band
normal
ratio
band
intens
lane
et
al
liu
et
al
analysi
perform
use
nih
imag
softwar
splenocyt
obtain
mhvinfect
mice
day
posttranspl
stimul
mhv
epitop
specif
either
cell
epitop
held
et
al
control
ovalbumin
ova
peptid
span
residu
use
h
supernat
collect
product
determin
use
quantikin
mous
immunoassay
kit
r
system
minneapoli
mn
mous
duoset
r
system
sampl
measur
duplic
cytokin
concentr
present
picogram
per
millilit
statist
differ
group
mice
determin
student
test
valu
p
consid
signific
glialcommit
progenitor
cell
dissect
striatal
region
brain
day
postnat
mice
cultur
day
use
transplant
result
growth
numer
neurospher
contain
progenitor
cell
fig
b
cell
character
immunostain
data
shown
confirm
major
cell
oligodendrocyt
progenitor
cell
previous
report
totoiu
et
al
differenti
cell
vitro
result
approxim
oligodendrocyt
astrocyt
cell
type
agreement
previou
studi
totoiu
et
al
result
agre
previou
find
transplant
glialcommit
progenitor
cell
mice
chronic
infect
mhv
day
pi
result
substanti
remyelin
day
posttranspl
evid
given
import
inflammatori
respons
initi
maintain
diseas
mhvinfect
mice
wu
et
al
sought
determin
one
mechan
transplant
progenitor
cell
promot
remyelin
modifi
sever
inflamm
address
question
first
evalu
leukocyt
infiltr
cn
flow
cytometri
day
posttransplant
glialcommit
progenitor
cell
dmem
control
day
pi
fig
overal
frequenc
infiltr
cell
cell
macrophag
high
alter
mice
receiv
progenitor
cell
compar
control
mice
fig
infiltr
virusspecif
cell
also
investig
frequenc
cell
specif
immunodomin
epitop
present
within
matrix
protein
residu
assess
intracellular
cytokin
stain
stimul
peptid
xue
et
al
frequenc
cell
modul
follow
transplant
glialcommit
progenitor
cell
compar
control
mice
fig
similarli
infiltr
virusspecif
cell
determin
use
mhc
tetram
contain
immunodomin
epitop
present
within
surfac
glycoprotein
residu
castro
perlman
result
analysi
demonstr
transplant
cell
alter
frequenc
cell
cn
compar
control
mice
fig
confirm
lack
immunomodul
follow
stem
cell
transplant
also
look
later
time
point
day
follow
transplant
day
pi
analysi
inflammatori
infiltr
cn
day
posttranspl
yield
similar
result
seen
day
posttranspl
fig
inde
percentag
infiltr
cell
cell
high
macrophag
equival
mice
receiv
cell
dmem
fig
frequenc
virusspecif
cell
assess
intracellular
cytokin
stain
follow
stimul
peptid
similar
mice
receiv
cell
control
dmem
fig
addit
frequenc
virusspecif
cell
assess
stain
tetram
ident
mice
receiv
cell
dmem
fig
character
impact
transplant
glialcommit
progenitor
cell
inflamm
evalu
express
mrna
transcript
chemokin
chemokin
receptor
cytokin
within
cn
experiment
group
mice
total
rna
isol
spinal
cord
brain
experiment
group
mice
day
posttranspl
day
pi
express
inflammatori
factor
receptor
analyz
rnase
protect
assay
rpa
fig
numer
chemokin
express
spinal
cord
day
pi
readili
detect
spinal
cord
detect
brain
transplant
glialcommit
progenitor
cell
alter
chemokin
express
either
spinal
cord
fig
brain
c
similar
level
mrna
transcript
chemokin
receptor
detect
within
spinal
cord
e
brain
f
mice
receiv
cell
dmem
addit
express
cytokin
within
cn
modul
follow
cell
transplant
fig
low
level
express
observ
group
experiment
anim
lastli
sought
investig
effect
transplant
glialcommit
progenitor
cell
mhvinfect
mice
may
h
h
respons
viral
antigen
cytokin
product
spleen
remov
mice
day
posttranspl
day
pi
puls
mhv
epitop
mhv
epitop
control
peptid
h
follow
secret
h
associ
h
associ
measur
cell
supernat
elisa
fig
respons
epitop
alter
splenocyt
mice
receiv
cell
transplant
skew
h
respons
favor
increas
h
cytokin
product
one
five
mice
receiv
cell
produc
low
amount
respons
mhv
epitop
howev
differ
signific
therapeut
target
ms
includ
inflamm
demyelin
axon
loss
chronic
stage
transplant
gliogen
cell
popul
potenti
address
latter
two
target
sever
report
demonstr
util
transplant
therapi
experiment
model
demyelin
earli
studi
brustl
et
al
show
inject
embryon
stem
cell
spinal
cord
myelindefici
rat
result
numer
myelin
axon
week
posttranspl
similarli
transplant
clonal
mous
neural
stem
cell
nsc
mice
spinal
cord
injuri
shown
support
axon
regener
lu
et
al
success
transplant
demonstr
use
cell
varieti
sourc
bone
marrow
stromal
cell
cultur
vitro
use
intrathec
transplant
rat
gammairradi
ethidium
bromid
lesion
result
remyelin
increas
conduct
veloc
week
follow
transplant
akiyama
et
al
transplant
nsc
variou
myelin
defici
anim
myelindefici
rat
hammang
et
al
shiver
mous
mitom
et
al
yandava
et
al
magfyn
fig
flow
analysi
leukocyt
infiltr
cn
day
posttranspl
show
modul
inflammatori
popul
within
cn
follow
transplant
compar
control
mice
leukocyt
isol
cn
sham
infect
mice
receiv
transplant
dmem
cell
flow
cytometri
perform
determin
infiltr
cell
cell
high
macrophag
intracellular
cytokin
stain
perform
determin
frequenc
cell
b
tetram
stain
use
identifi
antigenspecif
cell
c
defici
mous
ader
et
al
result
remyelin
addit
studi
use
nsc
isol
mous
spinal
cord
show
cell
longterm
surviv
vivo
surviv
week
follow
transplant
hypomyelin
magfyndefici
mice
ader
et
al
collect
studi
clearli
demonstr
efficaci
transplantmedi
cn
remyelin
anim
model
dysmyelin
hypomyelin
nonetheless
import
note
mani
anim
model
contain
critic
featur
ms
includ
astrogliosi
presenc
inflammatori
infiltr
given
inflammatori
natur
ms
fact
current
human
therapi
ms
immunosuppress
natur
rizvi
agiu
critic
understand
influenc
inflamm
abil
transplant
cell
popul
affect
remyelin
studi
use
eaeinduc
demyelin
evalu
efficaci
transplantmedi
remyelin
inflammatori
environ
transplant
clonal
oligodendrocyt
progenitor
cell
opc
rat
prior
induct
eae
result
cell
migrat
within
cn
local
inflammatori
lesion
surviv
day
post
transplant
week
recoveri
diseas
tourbah
et
al
likewis
transplant
adult
neural
stem
cell
mice
onset
eae
result
target
migrat
cell
area
damag
improv
clinic
diseas
well
reduc
demyelin
axon
loss
pluchino
et
al
follow
remyelin
rat
spinal
cord
mous
oligodendrogli
cell
subsequ
reject
cell
remov
immunosuppress
host
oligodendrocyt
remyelin
extens
rapid
indic
inflamm
associ
cell
reject
imped
repair
blakemor
et
al
studi
demonstr
remyelin
possibl
inflamm
inde
sever
studi
indic
inflamm
enhanc
surviv
transplant
cell
migrat
transplant
cell
remyelin
foot
blakemor
oleari
blakemor
tourbah
et
al
suggest
oligodendrocyt
progenitor
within
chronic
multipl
sclerosi
lesion
may
requir
induct
inflamm
enabl
prolifer
differenti
myelinogen
cell
foot
blakemor
thu
import
understand
immun
respons
instanc
success
remyelin
effort
develop
strategi
overcom
remyelin
failur
mechan
transplant
cell
facilit
remyelin
includ
replenish
opc
pool
ultim
enhanc
remyelin
suppress
local
inflammatori
gene
express
therebi
limit
access
inflammatori
cell
cn
amplif
growth
factor
associ
stimul
endogen
cell
initi
repair
time
remyelin
observ
previou
studi
suggest
transplant
cell
may
directli
remyelin
damag
axon
totoiu
et
al
furthermor
transplant
opc
deriv
human
embryon
stem
cell
shiver
model
dysmyelin
result
differenti
cell
oligodendrocyt
result
compact
myelin
format
provid
evid
transplant
progenitor
differenti
myelin
nake
axon
nistor
et
al
present
studi
examin
possibl
progenitor
cellinduc
remyelin
associ
attenu
cn
inflamm
strongli
associ
ongo
myelin
destruct
mice
persist
infect
mhv
transplantmedi
attenu
inflamm
would
improv
clinic
score
might
alter
capabl
endogen
cell
affect
remyelin
import
consider
design
therapeut
approach
treat
human
diseas
comprehens
overview
infiltr
leukocyt
cn
perform
fac
analysi
found
intrathec
transplant
progenitor
cell
mice
chronic
infect
mhv
modul
cell
macrophag
infiltr
cn
either
day
follow
transplant
fig
moreov
systemat
assess
express
chemokin
chemokin
receptor
cytokin
express
cn
rpa
support
find
inflamm
modul
follow
progenitor
cell
transplant
fig
mhvspecif
immun
modul
follow
transplant
infiltr
antigenspecif
similar
mice
receiv
transplant
progenitor
cell
dmem
fig
addit
h
express
mous
splenocyt
stimul
mhv
epitop
skew
mice
follow
transplant
fig
studi
provid
detail
analysi
state
immun
respons
follow
transplant
provid
strong
evid
transplant
glialcommit
progenitor
cell
result
immun
suppress
contrast
studi
prophylact
transplant
neural
precursor
cell
npc
rat
acut
eae
immunosuppress
effect
einstein
et
al
studi
report
reduc
perivascular
infiltr
mice
receiv
npc
well
decreas
prolifer
lymph
node
cultur
cocultur
npc
noteworthi
studi
differ
report
evalu
therapeut
effect
transplant
treat
demyelin
diseas
induc
viru
mhv
transplant
perform
diseas
onset
time
transplant
like
critic
influenc
develop
immun
respons
ongo
immun
respons
find
transplant
glialcommit
progenitor
cell
amelior
inflamm
novel
therapi
clinic
experiment
target
inflamm
improv
clinic
diseas
specif
experiment
neutral
chemokin
mice
chronic
infect
mhv
result
improv
clinic
histolog
diseas
reduc
infiltr
leukocyt
cn
well
reduc
infiltr
antigenspecif
cell
cn
glass
et
al
possibl
combin
therapeut
neutral
transplant
glialcommit
progenitor
cell
would
synerg
result
greater
degre
remyelin
studi
underway
evalu
benefit
combin
therapi
find
indic
transplantmedi
remyelin
mediat
accompani
reduc
inflammatori
respons
cn
first
time
repair
remyelin
mice
chronic
infect
mhv
document
absenc
reduc
inflamm
data
suggest
remyelin
occur
within
inflammatori
environ
depend
upon
modul
inflamm
factor
may
influenc
remyelin
transplant
glialcommit
progenitor
cell
includ
express
growth
factor
extracellular
matrix
molecul
studi
character
effect
transplant
immun
respons
cn
import
step
develop
transplantmedi
therapi
treat
demyelin
disord
importantli
transplant
reactiv
inflammatori
process
within
cn
addit
studi
underway
understand
mechan
transplant
cell
promot
remyelin
